Sequential Cu-catalyzed amidation-base-mediated camps cyclization: A two-step synthesis of 2-aryl-4-quinolones from o-halophenones

Journal of Organic Chemistry

Volumn 72, Issue 21, 2007, Pages 7968-7973

  Jones, Carrie P ^a   Anderson, Kevin W ^a   Buchwald, Stephen L ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINES; CATALYST ACTIVITY; COPPER COMPOUNDS; CYCLIZATION; LIGANDS; SYNTHESIS (CHEMICAL);

CATALYZED AMIDATION; DIAMINE LIGAND; HALOPHENONES; QUINOLONES;

AMIDES;

AMIDE; COPPER; DIAMINE; HALOGEN; LIGAND; POLYCYCLIC AROMATIC HYDROCARBON DERIVATIVE; QUINOLONE DERIVATIVE; VINYL DERIVATIVE;

ALDOL REACTION; AMIDATION; ARTICLE; CATALYSIS; CATALYST; CYCLIZATION; QUANTUM YIELD; REACTION ANALYSIS; SYNTHESIS;

ACETOPHENONES; BENZAMIDES; CATALYSIS; COPPER; CYCLIZATION; INDOLES; MOLECULAR STRUCTURE; QUINOLONES;

EID: 35348846488     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo701384n     Document Type: Article

References (70)

1. (a) Jiang, L.; Buchwald, S. L. In Metal-Catalyzed Cross-Coupling Reactions, 2nd ed.; de Meijere, A., Diederich, F., Eds.; Wiley-VCH: Weinheim, Germany, 2004; pp 699-760.
2. (b) Hartwig, J. F. Synlett 2006, 9, 1283-1294.
3. Zou, B.; Yuan, Q.; Ma, D. Angew. Chem., Int. Ed. 2007, 46, 2598-2601.
4. Martín, R.; Rodríguez Rivero, M.; Buchwald, S. L. Angew. Chem., Int. Ed. 2006, 45, 7079-7082.
5. Rodríguez Rivero, M.; Buchwald, S. L. Org. Lett. 2007, 9, 973-976.
6. (a) Ackermann, L. Org. Lett. 2005, 7, 439-442.
7. (b) Tang, Z.-Y.; Hu, Q.-S. Adv. Synth. Catal. 2006, 348, 846-850.
8. (c) Liu, F.; Ma, D. J. Org. Chem. 2007, ASAP.
9. Manley, P. J.; Bilodeau, M. T. Org. Lett. 2004, 6, 2433-2435.
10. Pozharskii, A. F.; Soldatenkov, A. T.; Katritzky, A. R. Heterocycles and Health. In Heterocycles in Life and Society; John Wiley: Chichester, UK, 1997; pp 135-164.
11. It is known that 4-quinolones have two tautomeric forms and can be drawn as either the 4-hydroxyquinolines in the enol-form or as 4-quinolones in the keto-form (Scheme 1). Both forms are important in understanding the characterization data and the chemical reactivity of such compounds. However, it is believed that in the solid state, as well as in many solvents, these compounds exist primarily in the keto-form. Therefore, for the purposes of this publication, we will refer to and draw the products as 4-quinolones. For discussions on the tautomerization of hydroxyquinolines see: (a) Reitsema, R. H. Chem. Rev. 1948, 43, 43-68.
12. (b) Katritzky, A. R.; Lagowski, J. M. Prototropic Tautomerism of Heteroaromatic Compounds: II. Six-Membered Rings. In Advances in Heterocyclic Chemistry; Katritzky, A. R., Ed.; Academic Press, Inc.: New York, 1963; Vol. 1, pp 339-437.
13. (c) Mphahlele, M. J.; El-Nahas, A. M. J. Mol. Struct. 2004, 688, 129-136.
14. (a) Osawa, T.; Ohta, H.; Akimoto, K.; Harada, K.; Soga, H.; Jinno, Y. 4(1H)quinolone Derivatives. Eur. Patent 0 343 574, 1994.
15. (b) Huang, L.-J.; Hsieh, M.-C.; Teng, C.-M.; Lee, K.-H.; Kuo, S.-C. Bioorg. Med. Chem. 1998, 6, 1657-1662.
16. (c) Takami, H.; Kishibayashi, N.; Ishii, A.; Kumazawa, T. Bioorg. Med. Chem. 1998, 6, 2441-2448.
17. (d) Lee, H.-Z.; Lin, W.-C.; Yeh, F.-T.; Wu, C.-H. Eur. J. Pharmacol. 1998, 354, 205-213.
18. (e) Jackson, S. P.; Robertson, A. D.; Kenche, V.; Thompson, P.; Prabaharan, H.; Anderson, K.; Abbott, B.; Goncalves, I.; Nesbitt, W.; Schoenwaelder, S.; Saylik, D. Inhibition of Phosphoinostide 3-Kinase Beta. PCT Int. Patent WO 2004/016607, 2004.
19. (f) Llinàs-Brunet, M.; Bailey, M. D.; Ghiro, E.; Gorys, V.; Halmos, T.; Poirier, M.; Rancourt, J.; Goudreau, N. J. Med. Chem. 2004, 47, 6584-6594.
20. (g) Wu, F. X. H.; Nakajima, S.; Or, Y. S.; Lu, Z.-H.; Sun, Y.; Miao, Z.; Wang, Z. Aza-Peptide Macrocyclic Hepatitis C Serine Protease Inhibitors. PCT Int. Patent WO 2005/010029, 2005.
21. (h) Pal, M.; Khanna, I.; Subramanian, V.; Padakanti, S.; Pillarisetti, S. Heterocyclic and Bicyclic Compounds, Compositions and Methods. PCT Int. Patent WO 2006/058201, 2006.
22. (i) Frutos, R. P.; Haddad, N.; Houpis, I. N.; Johnson, M.; Smith-Keenan, L. L.; Fuchs, V.; Yee, N. K.; Farina, V.; Faucher, A.-M.; Brochu, C.; Haché, B.; Duceppe, J.-S.; Beaulieu, P. Synthesis 2006, 2563-2567.
23. Selected references on 2-aryl-4-quinolones as antitumor agents: (a) Kuo, S.-C.; Lee, H.-Z.; Juang, J.-P.; Lin, Y.-T.; Wu, T.-S.; Chang, J.- J.; Lednicer, D.; Pauli, K. D.; Lin, C. M.; Hamel, E.; Lee, K.-H. J. Med. Chem. 1993, 36, 1146-1156.
24. (b) Li, L.; Wang, H.-K.; Kuo, S.-C.; Wu, T.-S.; Lednicer, D.; Lin, C. M.; Hamel, E.; Lee, K.-H. J. Med. Chem. 1994, 37, 1126-1135.
25. (c) Li, L.; Wang, H.-K.; Kuo, S.-C.; Wu, T.-S.; Mauger, A.; Lin, C. M.; Hamel, E.; Lee, K.-H. J. Med. Chem. 1994, 37, 3400-3407.
26. (d) Sui, Z.; Nguyen, V. N.; Altom, J.; Fernandez, J.; Hilliard, J. J.; Bernstein, J. I.; Barrett, J. F.; Ohemeng, K. A. Eur. J. Med. Chem. 1999, 34, 381-387.
27. (e) Xia, Y.; Yang, Z.-Y.; Xia, P.; Hackl, T.; Hamel, E.; Mauger, A.; Wu, J.-H.; Lee, K.-H. J. Med. Chem. 2001, 44, 3932-3936.
28. (f) Hadjeri, M.; Peiller, E.-L.; Beney, C.; Deka, N.; Lawson, M. A.; Durnontet, C.; Boumendjel, A. J. Med. Chem. 2004, 47, 4964-4970.
29. (g) Hradil, P.; Krejcí, P.; Hlavác, J.; Wiedermannová, I.; Lycka, A.; Bertolasi, V. J. Heterocycl. Chem. 2004, 41, 375-379.
30. (h) Lai, Y.-Y.; Hung, L.-J.; Lee, K.-H.; Xiao, Z.; Bastow, K. F.; Yamori, T.; Kuo, S.-C. Bioorg. Med. Chem. 2005, 13, 265-275.
31. (i) Ferlin, M. G.; Chiarelotto, G.; Gasparotto, V.; Via, L. D.; Pezzi, V.; Barzon, L.; Palu, G.; Castagliuolo, I. J. Med. Chem. 2005, 48, 3417-3427.
32. (j) Gasparotto, V.; Castagliuolo, I.; Chiarelotto, G.; Pezzi, V.; Montanaro, D.; Brun, P.; Palu, G.; Viola, G.; Ferlin, M. G. J. Med. Chem. 2006, 49, 1910-1915.
33. Conrad-Limpach type methods: (a) Li, J. J. Conrad-Limpach Reaction in Name Reactions: A Collection of Detailed Reaction Mechanisms, 2nd ed.; Springer-Verlag: Berlin, 2003; p 81.
34. (b) Staskun, B.; Israelstam, S. S. J. Org. Chem. 1961, 26, 3191-3193.
35. (c) Giardina, G. A. M.; Sarau, H. M.; Farina, C.; Medhurst, A. D.; Grugni, M.; Rveglia, L. F.; Schmidt, D. B.; Rigolio, R.; Luttmann, M.; Vecchietti, V.; Hay, D. W. P. J. Med. Chem. 1997, 40, 1794-1807.
36. For methods utilizing Eaton's reagent: (d) Dorow, R. L.; Herrinton, P. M.; Hohler, R. A.; Maloney, M. T.; Mauragis, M. A.; McGhee, W. E.; Moeslein, J. A.; Strohbach, J. W.; Veley, M. F. Org. Process Res. Dev. 2006, 10, 493-499.
37. (e) Zewge, D.; Chen, C.-Y.; Deer, C.; Dormer, P. G.; Hughes, D. L. J. Org. Chem. 2007, 72, 4276-4279.
38. Niementowski methods: (f) Niementowski, S. Ber. Dtsch. Chem. Ges. 1894, 27, 1394-1403.
39. (g) Fuson, R. C.; Burness, D. M. J. Am. Chem. Soc. 1946, 68, 1270-1272.
40. (h) Ogata, Y.; Kawasaki, A.; Tsujimura, K. Tetrahedron 1971, 27, 2765-2770.
41. (i) Son, J. K.; Kim, S. I.; Jahng, Y. Heterocycles 2001, 55, 1981-1986.
42. (a) Tang, J.; Huang, X. Synth. Commun. 2003, 33, 3953-3960.
43. (b) Beifuss, U.; Ledderhose, S. Synlett 1997, 313-315.
44. (c) Strekowski, L.; Wydra, R. L.; Cegla, M. T.; Czarny, A.; Harden, D. B.; Patterson, S. E.; Battiste, M. A.; Coxon, J. M. J. Org. Chem. 1990, 55, 4777-4779.
45. (a) Kalinin, V. N.; Shostakovsky, M. V.; Ponomaryov, A. B. Tetrahedron Lett. 1992, 33, 373-376.
46. (b) Torii, S.; Okumoto, H.; Xu, L. H.; Sadakane, M.; Shostakovsky, M. V.; Ponomaryov, A. B.; Kalinin, V. N. Tetrahedron 1993, 49, 6773-6784.
47. Fürstner, A.; Hupperts, A.; Ptock, A.; Janssen, E. J. Org. Chem. 1994, 59, 5215-5229.
48. Tollari, S.; Cenini, S.; Ragaini, F.; Cassar, L. J. Chem. Soc., Chem. Commun. 1994, 1741-1742.
49. (a) Camps, R. Chem. Ber. 1899, 32, 3228-3234.
50. (b) Pflum, D. A. Camps Quinolinol Synthesis. In Name Reactions in Heterocyclic Chemistry; Li, J. J., Corey, E. J., Eds.; Wiley-Interscience: Hoboken, NJ, 2005; pp 386-389.
51. (a) Clémence, F.; Le Martret, O.; Collard, J. J. Heterocycl. Chem. 1984, 21, 1345-1353.
52. (b) Dubroeucq, M.-C.; Bains, E. L.; Paris, J.-M.; Marne, V. S.; Renault, C. Quinolyloxyacetamides. U.S. Patent 5017576, 1991.
53. (c) Hadjeri, M.; Mariotte, A.-M.; Boumendjel, A. Chem. Pharm. Bull. 2001, 49, 1352-1355.
54. (d) Ding, D.; Li, X.; Wang, X.; Du, Y.; Shen, J. Tetrahedron Lett. 2006, 47, 6997-6999.
55. Fürstner, A.; Jumbam, D. N. Tetrahedron 1992, 48, 5991-6010.
56. For a review: Fürstner, A.; Bogdanovic, B. Angew. Chem., Int. Ed. Engl. 1996, 35, 2442-2469.
57. (a) Klapars, A.; Antilla, J. C.; Huang, X.; Buchwald, S. L. J. Am. Chem. Soc. 2001, 123, 7727-7729.
58. (b) Klapars, A.; Huang, X.; Buchwald, S. L. J. Am. Chem. Soc. 2002, 124, 7421-7428.
59. (c) Streiter, E. R.; Blackmond, D. G.; Buchwald, S. L. J. Am. Chem. Soc. 2005, 127, 4120-4121.
60. References indicating catalyst-free amination reactions: (a) Beller, M.; Breindl, C.; Riermeier, T. H.; Tillack, A. J. Org. Chem. 2001, 66, 1403-1412.
61. (b) Shi, L.; Wang, M.; Fan, C.-A.; Zhang, F.-M.; Tu, Y.-Q. Org. Lett. 2003, 5, 3515-3517.
62. (c) De Lange, B.; Lambers-Verstappen, M. H.; Schmieder-van de Vondervoort, L.; Sereinig, N.; de Rijk, R.; de Vries, A. H. M.; de Vries, J. G. Synlett 2006, 18, 3105-3109.
63. (a) Lindley, J. Tetrahedron 1984, 40, 1433-1456.
64. (b) Nicolaou, K. C.; Boddy, C. N. C.; Natarajan, S.; Yue, T.-Y.; Li, H.; Bräse, Ramanjulu, J. M. J. Am. Chem. Soc. 1997, 119, 3421-3422.
65. (c) Cai, Q.; Zou, B.; Ma, D. Angew. Chem., Int. Ed. 2006, 45, 1276-1279.
66. Aryl iodides were found to be better starting materials for the more difficult Cu-catalyzed amidation reactions of 2-halophenones with alkyl amides, which are not discussed in this publication due to their problematic reactivity in the Camps cyclization.
67. 4 for the facilitation of Cu-catalyzed amidation with aryl iodides reported in our earlier work (ref 20b).
68. (a) Klapars, A.; Buchwald, S. L. J. Am. Chem. Soc. 2002, 124, 14844-14845.
69. (b) Antilla, J. C.; Baskin, J. M.; Barder, T. E.; Buchwald, S. L. J. Org. Chem. 2004, 69, 5578-5587.
70. For example, N-(2-acetylphenyl)-n-hexanamide (32) cyclized to afford 25% of 4-methyl-3-n-butyl-2-quinolone (33) and 49% of 2-n-pentyl-4-quinolone (34).